Ittai Harel has served as a member of our board of directors since August 2019. Mr. Harel is a Managing General Partner with Pitango Venture Capital. His investment focus is in the biotechnology and healthcare industries, and includes digital health, medical devices, diagnostics, and specialty pharma. Before joining Pitango, Mr. Harel headed up Corporate Development at Nektar Therapeutics and served as Executive Vice President at IDGene Pharmaceuticals, Inc. He also served as head of business development at IDEXX Laboratories, Inc. Mr. Harel currently serves on the boards of directors of DouxMatok, CLEW Medical, LifeBond Ltd., EarlySense, Medisafe, Vertos Medical Inc., ImmuneID, Inc., ProtAI, Altesa Biosciences, Inc., and Visby Medical, Inc., and serves as Chairman of the Board at EarlySense.
Mr. Harel holds a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, and an M.B.A. from the Sloan School of Management.